We are writing to introduce you to the updated and simplified Code of Professional Practice and Ethics for IOT Trichologists. While the principles of the Code remain consistent with its previous version, we have taken steps to improve its clarity and presentation. These changes are designed to make it easier for you to understand and […]
Updated and simplified Code of Ethics Read More »
We hope this message finds you well. We are writing to inform you of an important update regarding the annual Continuing Professional Development (CPD) points requirement. Starting this year, we will be increasing the CPD points requirement from 5 points to 10 points per annum. This is part of a gradual phased increase, with the
Important Update: Increase in CPD Points Requirement Read More »
As part of our ongoing commitment to the high professional standards and ensuring compliance with current regulations, we are writing to advise you of your legal obligation to comply to the guidelines set forth by the Information Commissioners Office (ICO); Which is that you display a clear and comprehensive ‘privacy notice’ on your websites. This
Important Compliance Requirements: Privacy Notice, Patient Records, and ICO Registration Read More »
As a valued member of our healthcare community, your dedication to providing exceptional care and service is greatly appreciated. To maintain the highest standards of safety and trust, we believe it is crucial for all healthcare providers to complete a Disclosure and Barring Service (DBS) check. The Benefits and Necessity of a Standard DBS Check
Important Update: Apply for Your Standard DBS Check Today Read More »
Speaker: Dr George Moncrieff FRCP FRCGP DCH DRCOG DPD Your next webinar of 2024 is “My approach to managing scalp psoriasis and seborrheic dermatitis in Primary Care” presented by Dr George Moncrieff FRCP FRCGP DCH DRCOG DPD, on Monday 24th June 2024 at 11:30am. Dr George Moncrieff has been a GP for 40 years. In
“New one-a-day tablet for people with severe hair loss due to alopecia areata recommended by NICE Thousands of people with severe hair loss due to alopecia areata are set to benefit from a new one-a-day capsule to help treat the condition. Ritlecitinib (also known as Litfulo and made by Pfizer) is recommended by NICE as
Company Registration Number: 00208098
Company Address: 10 Harley Street, London, W1G 9PF
